טוען...
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss
Background and aims: A substantial proportion of patients with inflammatory bowel disease (IBD) develops osteopenia and osteoporosis in the course of disease. Recent data from a mouse model of colitis suggest that the receptor activator of nuclear factor kappa B (RANKL)/osteoprotegerin (OPG) system...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Copyright 2005 by Gut
2005
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1774465/ https://ncbi.nlm.nih.gov/pubmed/15753532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.044370 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|